Evidence map›Paper›PMID 37649018›Full record

SynthesisBMC health services research2023

Intervention of pharmacist included in multidisciplinary team to reduce adverse drug event: a qualitative systematic review.

Sarah Zaij, Kelly Pereira Maia, Géraldine Leguelinel-Blache, Clarisse Roux-Marson, Jean Marie Kinowski, Hélène Richard

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC health services research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Tackling medication errors: how a systems approach improves patient safety.European journal of hospital pharmacy : science and practice · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sarah ZaijDepartment of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France. sarah.zaij@etu.univ-amu.fr.
Kelly Pereira MaiaDepartment of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France.
Géraldine Leguelinel-BlacheDepartment of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France.
Clarisse Roux-MarsonDepartment of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France.
Jean Marie KinowskiDepartment of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France.
Hélène RichardDepartment of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France.
Inserm · FRUniversité de Montpellier · FRUniversité de Nîmes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreventable harm in healthcare is a growing public health challenge. In addition to the economic costs of safety failures, adverse drug events (ADE) may lead to complication or even death. Multidisciplinary care team involving a pharmacist appears to be an adequate response to prevention of adverse drug event. This qualitative systematic review aims to identify and describe multidisciplinary planned team-based care involving at least one pharmacist to limit or prevent adverse drug events in the adult patients.

methodsTo determine the type of interprofessional collaboration to prevent adverse drug event in which a pharmacist was involved, we conducted a qualitative systematic review of the literature of randomized controlled trials. Two independent reviewers screened trials in three databases: Medline, Web of Science, ScienceDirect. Prospective studies of at least three different health professionals' interventions, one of whom was a pharmacist in the last five years were included. Two reviewers performed data extraction and quality appraisal independently. We used TIDieR checklist to appraise articles quality.

resultsIn total 803 citations were retrieved, 34 were analysed and 16 full-text articles were reviewed. Only 3 studies published an implementation evaluation. More than half of the interventions (62%) targeted elderly patients including 6 whom lived in nursing homes. Studies outcomes were heterogeneous, and we did not perform a statistical analysis of the impact of these interventions. Most teams are composed of a physician/pharmacist/nurse trio (94%; 100%; 88%). Half of the teams were composed of the primary care physician. Other professionals were included such as physical therapists (25%), social worker (19%), occupational therapists (12%), and community health educator (6%). Multidisciplinary medication review was the most common intervention and was generally structured in four steps: data collection and baseline assessment, appraisal report by health professionals, a multidisciplinary medication review meeting and a patient follow-up.

conclusionsThe most common multidisciplinary intervention to prevent ADE in the adult population is the multidisciplinary drug review meeting at least the physician/pharmacist/nurse trio. Interventions target mostly elderly people in nursing homes, although complex chronic patients could benefit from this type of assessment.

trial registrationPROSPERO registration: CRD42022334685.

Indexed as

Drug-Related Side Effects and Adverse ReactionsPhysical TherapistsAdultAgedChecklistHumansNursing HomesPatient Care TeamPharmacistsProspective StudiesAdverse drug eventClinical pharmacistDrug-related problemsMultidisciplinary team

Identifiers

PMID37649018
PMCPMC10470127
OpenAlexW4386284852

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.